Suppr超能文献

肝素诱导的血小板减少症和血栓形成:病例研究及临床概述

Heparin-induced thrombocytopenia and thrombosis: a case study and clinical overview.

作者信息

Lapka D M, Wild L D, Barbour L A

机构信息

Division of Surgical Oncology, University of Illinois, Chicago Specialized Cancer Center.

出版信息

Oncol Nurs Forum. 1994 Jun;21(5):871-6.

PMID:7937248
Abstract

PURPOSE/OBJECTIVES: To describe the mechanisms and nursing care associated with heparin-induced thrombocytopenia and thrombosis (HITT).

DATA SOURCES

Published books and journal articles as well as clinical experience.

DATA SYNTHESIS

HITT is an immune reaction that occurs in 1%-10% of individuals receiving heparin therapy. Characterized by a sudden drop in platelets, it can result in life-threatening hemorrhage and thrombus-related events.

CONCLUSIONS

Heparin commonly is used in many oncology treatment settings. Awareness of this potentially serious complication and knowledge of its treatment is critical to safe administration.

IMPLICATIONS FOR NURSING PRACTICE

Astute assessment skills are the key to diagnosis and treatment of HITT.

摘要

目的/目标:描述肝素诱导的血小板减少症和血栓形成(HITT)的机制及护理。

资料来源

已出版的书籍、期刊文章以及临床经验。

资料综合

HITT是一种免疫反应,发生于1% - 10%接受肝素治疗的个体中。其特征为血小板突然减少,可导致危及生命的出血和血栓相关事件。

结论

肝素常用于多种肿瘤治疗环境中。认识到这种潜在的严重并发症及其治疗知识对于安全用药至关重要。

对护理实践的启示

敏锐的评估技能是HITT诊断和治疗的关键。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验